KR890002402A - 인간의 유두종바이러스형 41, 이의 dna 및 이로부터 코드화된 단백질 - Google Patents
인간의 유두종바이러스형 41, 이의 dna 및 이로부터 코드화된 단백질 Download PDFInfo
- Publication number
- KR890002402A KR890002402A KR1019880008579A KR880008579A KR890002402A KR 890002402 A KR890002402 A KR 890002402A KR 1019880008579 A KR1019880008579 A KR 1019880008579A KR 880008579 A KR880008579 A KR 880008579A KR 890002402 A KR890002402 A KR 890002402A
- Authority
- KR
- South Korea
- Prior art keywords
- dna
- protein
- hpv
- proteins encoded
- human papillomavirus
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title claims 8
- 108090000623 proteins and genes Proteins 0.000 title claims 8
- 241000701825 Human papillomavirus type 41 Species 0.000 title 1
- 229940039227 diagnostic agent Drugs 0.000 claims 3
- 239000000032 diagnostic agent Substances 0.000 claims 3
- 208000015181 infectious disease Diseases 0.000 claims 3
- 238000010353 genetic engineering Methods 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 238000011282 treatment Methods 0.000 claims 2
- 238000001574 biopsy Methods 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 claims 1
- 238000002255 vaccination Methods 0.000 claims 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/708—Specific hybridization probes for papilloma
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 제한 효소분해에 대한 물리적 게놈(genome)도표.
제2도는 HPV 41과 HPV 8의 상결성(colinearitg)을 나타낸 도표.
Claims (12)
- 클론 K10 및 K6을 특징으로 하는 HPV 41 DNA.
- 유전공학으로 수득가능한 HPV 41의 발현생성물(단백질).
- 항체를 제조하기 위한 제2항에 따른 발현생성물(단밸직)의 용도.
- HPV 41의 발현생성물에 대한 모노-또는 폴리클로널 항체.
- 제4항에 따른 항체를 함유하는 진단용 제제(diagnostic).
- 생검 또는 도말표본 물질을 제5항에 따른 진단용제제와 접촉시킴을 특징으로하여, HPV 41감염을 진단하는 방법.
- 단백질의 유전 공학적 제조에 사용하기 위한 제2항에 따른 단백질을 코드화하는 DNA의 용도.
- HPV 41감염을 진단하기 위한 제2항에 따른 단백질을 코드화하는 DNA 또는 이의 일부의 용도.
- 제2항에 따른 단백질을 코드화하는 DNA 또는 이 DNA의 일부를 함유하는 진단용제제.
- 연구중인 RNA 또는 DNA를, 제2항에 따른 단백질 또는 이 단백질의 일부를 코드화하는 DNA와 하이브리드화시킴(hybridizing)을 특징으로하여, HPV 41감염을 진단하는 방법.
- 예방접종 및 치료에 사용하기 위한 제2항에 따른 생성물의 용도.
- 예방 및 치료에 사용하기 위한 제1항에 따른 생성물의 용도.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP3722968.0 | 1987-07-11 | ||
DE19873722968 DE3722968A1 (de) | 1987-07-11 | 1987-07-11 | Humaner papillomvirus typ 41, seine dna und die dafuer kodierenden proteine |
Publications (2)
Publication Number | Publication Date |
---|---|
KR890002402A true KR890002402A (ko) | 1989-04-10 |
KR970005047B1 KR970005047B1 (ko) | 1997-04-11 |
Family
ID=6331386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019880008579A KR970005047B1 (ko) | 1987-07-11 | 1988-07-11 | 사람의 유두종 바이러스 타입 41, 이의 dna 및 이로부터 암호화된 단백질 |
Country Status (12)
Country | Link |
---|---|
US (2) | US5142032A (ko) |
EP (1) | EP0301289B1 (ko) |
JP (1) | JP2746380B2 (ko) |
KR (1) | KR970005047B1 (ko) |
AT (1) | ATE111158T1 (ko) |
AU (1) | AU617330B2 (ko) |
CA (1) | CA1340322C (ko) |
DE (2) | DE3722968A1 (ko) |
DK (1) | DK173259B1 (ko) |
ES (1) | ES2060625T3 (ko) |
FI (1) | FI100538B (ko) |
PT (1) | PT87940B (ko) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1486211B1 (en) | 1993-04-30 | 2008-10-22 | Wellstat Biologics Corporation | Compositions for treating cancer using viruses |
DE19526386C1 (de) * | 1995-07-19 | 1997-01-02 | Deutsches Krebsforsch | Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen |
CA2365901A1 (en) * | 1999-04-14 | 2000-10-19 | Musc Foundation For Research Development | Tissue-specific and pathogen-specific toxic agents and ribozymes |
US20030059806A1 (en) * | 2001-01-05 | 2003-03-27 | Science & Technology Corporation @ Unm | Probes for the detection of human papillomavirus |
US7704965B2 (en) * | 2002-06-26 | 2010-04-27 | The Penn State Research Foundation | Methods and materials for treating human papillomavirus infections |
EP2576840B1 (en) | 2010-05-25 | 2018-10-17 | QIAGEN Gaithersburg, Inc. | Fast results hybrid capture assay and associated strategically-truncated probes |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2648303B2 (ja) * | 1985-04-04 | 1997-08-27 | ジョージタウン・ユニバーシティ | 型特異的乳頭腫ウイルスdna配列およびペプチド |
DE3625257A1 (de) * | 1986-07-23 | 1988-02-04 | Behringwerke Ag | Expressionsprodukte der menschlichen papillomviren typ 16 und 18, fuer diese proteine spezifische antikoerper und diese antikoerper bzw. entsprechende dna enthaltende diagnostika |
US4849331A (en) * | 1987-06-09 | 1989-07-18 | Life Technologies, Inc. | Human papillomavirus 44 nucleic acid hybridization probes and methods for employing the same |
US4849334A (en) * | 1987-06-09 | 1989-07-18 | Life Technologies, Inc. | Human papillomavirus 43 nucleic acid hybridization probes and methods for employing the same |
DE3722967A1 (de) * | 1987-07-11 | 1989-01-19 | Behringwerke Ag | Monoklonale antikoerper gegen e7-protein des humanen papillomvirus typ 16, verfahren zu ihrer herstellung sowie ihre verwendung |
DE3826793A1 (de) * | 1988-08-06 | 1990-03-08 | Behringwerke Ag | Humaner papillomvirus typ 57, seine dna und die davon kodierten proteine |
-
1987
- 1987-07-11 DE DE19873722968 patent/DE3722968A1/de not_active Withdrawn
-
1988
- 1988-07-07 FI FI883255A patent/FI100538B/fi not_active IP Right Cessation
- 1988-07-07 AT AT88110851T patent/ATE111158T1/de not_active IP Right Cessation
- 1988-07-07 DE DE3851391T patent/DE3851391D1/de not_active Expired - Fee Related
- 1988-07-07 ES ES88110851T patent/ES2060625T3/es not_active Expired - Lifetime
- 1988-07-07 EP EP88110851A patent/EP0301289B1/de not_active Expired - Lifetime
- 1988-07-08 PT PT87940A patent/PT87940B/pt not_active IP Right Cessation
- 1988-07-08 DK DK198803834A patent/DK173259B1/da not_active IP Right Cessation
- 1988-07-08 CA CA000571554A patent/CA1340322C/en not_active Expired - Fee Related
- 1988-07-08 AU AU18878/88A patent/AU617330B2/en not_active Ceased
- 1988-07-08 US US07/216,913 patent/US5142032A/en not_active Expired - Lifetime
- 1988-07-11 JP JP63172512A patent/JP2746380B2/ja not_active Expired - Fee Related
- 1988-07-11 KR KR1019880008579A patent/KR970005047B1/ko not_active IP Right Cessation
-
1993
- 1993-11-23 US US08/156,936 patent/US5382509A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU617330B2 (en) | 1991-11-28 |
PT87940A (pt) | 1989-06-30 |
DK173259B1 (da) | 2000-05-29 |
DK383488D0 (da) | 1988-07-08 |
FI883255A0 (fi) | 1988-07-07 |
JP2746380B2 (ja) | 1998-05-06 |
US5382509A (en) | 1995-01-17 |
EP0301289B1 (de) | 1994-09-07 |
EP0301289A1 (de) | 1989-02-01 |
CA1340322C (en) | 1999-01-19 |
JPS6455182A (en) | 1989-03-02 |
AU1887888A (en) | 1989-04-20 |
PT87940B (pt) | 1995-03-01 |
DE3722968A1 (de) | 1989-01-19 |
ES2060625T3 (es) | 1994-12-01 |
KR970005047B1 (ko) | 1997-04-11 |
ATE111158T1 (de) | 1994-09-15 |
DK383488A (da) | 1989-01-12 |
DE3851391D1 (de) | 1994-10-13 |
FI883255A (fi) | 1989-01-12 |
FI100538B (fi) | 1997-12-31 |
US5142032A (en) | 1992-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI860015A (fi) | Menetelmä rokotteen valmistamiseksi piluksia kantavien nisäkkään kudoksiin tarttuvien bakteerien aiheuttamia tauteja vastaan | |
DE3750615D1 (de) | Hemmung von htlv-iii durch exogene oligonukleotide. | |
DE69333802T8 (de) | Äusseres membranprotein von haemophilus | |
CA2071196A1 (en) | Recombinant expression vectors and purification methods for thermus thermophilus dna polymerase | |
SE8703225L (sv) | Monoklonala antikroppar och peptider anvendbara vid behandling och diagnostisering av hiv-infektioner | |
PT83255B (pt) | Polipeptidos e anticorpos, caracteristicos do polilomavirus e suas aplicacoes no diagnostico "in vitro" na pervencao e ou na luta contra as infeccoes por papilomavirus | |
RU2218181C2 (ru) | ЧЕЛОВЕЧЕСКИЙ СЕМАФОРИН L(H-Sema-L) И СООТВЕТСТВУЮЩИЕ СЕМАФОРИНЫ В ДРУГИХ ВИДАХ | |
EP0554389A4 (en) | Molecular clones of hiv-1 and uses thereof | |
KR890002402A (ko) | 인간의 유두종바이러스형 41, 이의 dna 및 이로부터 코드화된 단백질 | |
EP0248534A3 (en) | Method of detecting aids virus infection | |
KR890008317A (ko) | 유전학적 조작에 의한 응고억제성 단백질 pp4의 제조방법 | |
Jacquemin et al. | Antibody response in cats to feline leukemia virus reverse transcriptase under natural conditions of exposure to the virus | |
JPH01503436A (ja) | 少数ライノウイルスレセプターグループのレセプター | |
KR890013181A (ko) | 플라스모듐 팔시파럼(plasmodium falciparum)의 주위 포자소체 유전자로부터 유도된 재조합 단백질의 제조방법 | |
Vaughan et al. | The identification of myrosinase after the electrophoresis of Brassica and Sinapis seed proteins | |
AU1540795A (en) | Diagnosis and treatment of infections due to streptococci and enterococci | |
KR890008316A (ko) | 항응고성 단백질 pp4-x, 및 이의 제조방법 및 용도 | |
Kozikowski et al. | Interferon induction by the psittacosis agent in guinea pig leukocyte cultures | |
GB1356503A (en) | Diagnostic method and means therefor | |
Wood et al. | Precipitin reaction obtainable between human serum and extracts of group A, type 15 streptococci. | |
Chopra | Rapid diagnosis of microbial infections by gas chromatography. | |
Bukrinskaia et al. | Rapid diagnosis of rotavirus infections by RNA electrophoresis on polyacrylamide gel | |
KR880010133A (ko) | Hiv 검출 및 치료를 위한 방법 및 물질 | |
KR900014595A (ko) | 태반 단백질 9(PP9)의 암호화 cDNA, 이의 분리방법 및 용도 | |
Dimitrova-Diminarova et al. | Establishment of B cell line producing human antisperm antibodies by Epstein-Barr virus transformation of peripheral blood lymphocytes from infertile women with sperm immobilizing antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20050830 Year of fee payment: 9 |
|
LAPS | Lapse due to unpaid annual fee |